Canterbury, UK: Britain is rolling out meningitis vaccinations to students at the University of Kent following a deadly outbreak that has claimed two lives and infected at least 20 people. Health officials have described the outbreak as ‘unprecedented in its spread.’
A 21-year-old university student and a teenage pupil from Faversham have died. Most cases involve the group B strain of meningococcal bacteria (MenB), which is known to cause severe meningitis and septicaemia. Officials are also monitoring a baby with a confirmed MenB infection, unrelated to the current outbreak.
Students at risk
Symptoms of meningitis and septicaemia include fever, headache, vomiting, rapid breathing, shivering, drowsiness, and a distinctive rash that does not fade under pressure.
Young adults in universities are particularly vulnerable due to close living conditions and social interactions.
Authorities have linked the majority of cases to the Club Chemistry nightclub in Canterbury between March 5 and 7. In response, around 2,500 doses of antibiotics have already been distributed across affected sites.
Eligible students at the University of Kent will have received an invite for vaccination.
For wider information on the meningitis outbreak, read our blog post.
🔗 https://t.co/xhhIekjbUL pic.twitter.com/wJMS2KbOdR
— UK Health Security Agency (@UKHSA) March 18, 2026
Targeted Vaccination Program
The UK Health Security Agency (UKHSA), in coordination with the NHS, is offering the MenB vaccine to 5,000 University of Kent students living on the Canterbury campus, with plans to extend if necessary. GSK is working closely with UK authorities to support the targeted vaccination effort.
While the vaccine is effective, reducing the risk of MenB by 70–85 percent, protection takes one to two weeks to develop. Health experts stress the importance of preventative antibiotics for those exposed during this period.
Health Secretary Wes Streeting emphasized that while meningitis remains a serious illness, the overall risk to the public is low, with Britain typically seeing around 350 cases annually.
